RegInfo: The international database of regulated information of listed companies

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DELEK GROUP
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- Phoenix Group Holdings
- POALIM
- SHUFERSAL
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

PERIODIC INFORMATION

ANNUAL FINANCIAL REPORT	HALF-YEAR FINANCIAL	QUARTERLY INFORMATION
FIPP INTEXA Prologue	Foncière 7 Investissement Apple Inc. VISA Inc	Grindeks Hiolle Industries Renault S.A.
More documents (18190)	More documents (20015)	More documents (35032)
REGISTRATION DOCUMENT	20F	STATUTORY AUDITORS C
Natixis Natixis Orpea	BlackBerry ARGENX Total SA	CRCAM de Paris et d'Ile de France CRCAM Normandie Seine Natixis
More documents (6127)	More documents (484)	More documents (1738)
AGM	INTERNAL CONTROL	ANNUAL INFO MEMO ART
Memscap DNO INTERNATIONAL Pro Kapital	Legrand Legrand Capgemini	CRCAM Alpes Provence Telia Rokiskio Suris
More documents (12570)	More documents (2318)	More documents (1333)

PERMANENT INFORMATION

2020.05.29 | 14:00 | Permanent Information Releases / General Company News

NOVARTIS

Novartis announces long-term, relapse-free survival benefit for high-risk, stage III melanoma patients treated with Tafinlar® + Mekinist® following surgery - HTML (w)

2020.05.29 | 14:00 | Permanent Information Releases / Sales and Revenues

SANOFI-AVENTIS

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time - HTML (w)

2020.05.29 | 14:00 | Permanent Information Releases / Sales and Revenues

SANOFI-AVENTIS

Les résultats à long terme de Libtayo® (cemiplimab-rwlc) dans le traitement du carcinome épidermoïde cutané présentés à l'ASCO 2020 montrent des réponses durables et plus prononcées au fil du temps - HTML (w)

2020.05.29 | 13:44 | Permanent Information Releases / General Company News

TALLINNA SADAM

Lifting of restrictions on passenger movement to Estonia for citizens of European countries - HTML (w)

2020.05.29 | 12:46 | Permanent Information Releases / General Company News

YARA

Share purchase by Yara Management - HTML (w)

More documents (293899)

Financial transactions

2020.05.29 | 14:00 | Permanent Information Releases / General Company News

NOVARTIS

Novartis announces long-term, relapse-free survival benefit for high-risk, stage III melanoma patients treated with Tafinlar® + Mekinist® following surgery - HTML (w)

2020.05.29 | 14:00 | Permanent Information Releases / Sales and Revenues

SANOFI-AVENTIS

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time - HTML (w)

2020.05.29 | 14:00 | Permanent Information Releases / Sales and Revenues

SANOFI-AVENTIS

Les résultats à long terme de Libtayo® (cemiplimab-rwlc) dans le traitement du carcinome épidermoïde cutané présentés à l'ASCO 2020 montrent des réponses durables et plus prononcées au fil du temps - HTML (w)

2020.05.29 | 13:44 | Permanent Information Releases / General Company News

TALLINNA SADAM

Lifting of restrictions on passenger movement to Estonia for citizens of European countries - HTML (w)

2020.05.29 | 12:46 | Permanent Information Releases / General Company News

YARA

Share purchase by Yara Management - HTML (w)

More documents (5626)